Key Takeaways Enterprise posted Q2 earnings of 66 cents per unit, topping estimates and last year's 64 cents. EPD quarterly revenues totaled $11.4B, missing estimates and down from $13.5B a year ago. Record natural gas processing and pipeline volumes boosted quarterly performance. Enterprise Products Partners LP’s (EPD) second-quarter 2025 adjusted earnings per limited partner unit of 66 cents beat the Zacks Consensus Estimate of 65 cents. The bottom line also increased from the year-ago level of 64 cents.H ...

Nov Inc. (NOV) reported $2.19 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 1.3%. EPS of $0.29 for the same period compares to $0.57 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $2.15 billion, representing a surprise of +1.85%. The company delivered an EPS surprise of -3.33%, with the consensus EPS estimate being $0.30.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...

Key Takeaways Q1 EPS rose 7.25% to $1.48, beating estimates by 1.4%, while revenues dipped 0.6% to $2.92B.The total backlog grew 10.7% to $38B, but the funded backlog and book-to-bill ratio declined year over year.FY26 EPS forecast is $6.20-$6.55; revenue growth is projected at 0-4%, with free cash flow of $900M-$1B.Booz Allen Hamilton Holding Corp. (BAH) reported mixed first-quarter fiscal 2026 results, wherein earnings beat the Zacks Consensus Estimate, but revenues missed the same. However, the earnings ...

Business First (BFST) reported $81.46 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 23.1%. EPS of $0.66 for the same period compares to $0.64 a year ago.The reported revenue represents a surprise of +3.29% over the Zacks Consensus Estimate of $78.86 million. With the consensus EPS estimate being $0.65, the EPS surprise was +1.54%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determi ...

财务表现 - 2025年第二季度营收7亿2028万美元，同比增长4.1% [1] - 每股收益1.18美元，低于去年同期的1.22美元 [1] - 营收超出Zacks共识预期71127万美元，超预期幅度1.27% [1] - 每股收益超出Zacks共识预期1.14美元，超预期幅度3.51% [1] 业务细分 - 生命科学业务净销售额3亿6590万美元，同比增长16.6%，远超分析师预期的3亿4232万美元 [4] - 诊断业务净销售额3亿5439万美元，同比下降6.3%，低于分析师预期的3亿6599万美元 [4] - 整体有机收入增长3%，略低于分析师平均预期的3.1% [4] - 生命科学有机收入增长4%，高于分析师预期的2.2% [4] - 诊断有机收入增长2%，低于分析师预期的3.8% [4] 市场表现 - 过去一个月股价上涨6%，跑赢标普500指数4.9%的涨幅 [3] - 当前Zacks评级为3级（持有），预示短期表现可能与大盘同步 [3]

BCB Bancorp (BCBP) reported $25.18 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 23.4%. EPS of $0.18 for the same period compares to $0.14 a year ago.The reported revenue represents a surprise of +8.32% over the Zacks Consensus Estimate of $23.25 million. With the consensus EPS estimate being $0.18, the company has not delivered EPS surprise.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare ...

Key Takeaways CHTR reported Q2 EPS of $9.18, missing estimates by 8.66% but rising 8.1% year over year.Q2 revenues grew 0.6% year over year to $13.8B, beating estimates by 0.41%.Growth in mobile and Internet offset declines in video, voice and advertising revenues.Charter Communications (CHTR) has reported second-quarter 2025 earnings of $9.18 per share, which missed the Zacks Consensus Estimate by 8.66%. However, the reported figure increased 8.1% year over year.Revenues of $13.8 billion increased 0.6% yea ...

公司业绩 - 第二季度调整后每股收益(EPS)为6.84美元 超出市场预期10.5% 同比增长24.4% [1] - 营业收入达186亿美元 同比增长6.4% 超出预期0.7% [1] - 调整后EBITDA为38亿美元 同比增长8.4% 超出预期36亿美元 [5] - 同院区等效入院量增长1.7% 同院区入院量增长1.8% 但低于预期的3.8%和4% [3] - 同院区每等效入院收入增长4% 高于预期的3.2% [3] 运营情况 - 同院区住院手术量下降0.3% 低于预期的1.5%增长 [4] - 同院区门诊手术量下降0.6% [4] - 急诊就诊量增长1.3% [4] - 薪资福利和供应成本总计147.8亿美元 同比增长6% 低于预期的148.4亿美元 [4] - 截至2025年6月30日 运营191家医院和约2500个门诊护理点 [5] 财务状况 - 现金及等价物为9.39亿美元 较2024年底下降51.4% [6] - 长期债务394亿美元 较2024年底增长2.7% [7] - 短期借款和一年内到期长期债务总计51亿美元 [7] - 上半年经营活动现金流59亿美元 同比增长32% [8] - 总资产595亿美元 较2024年底略有增长 [6] 资本运作 - 第二季度回购25亿美元股票 剩余授权额度58亿美元 [10] - 宣布每股0.72美元股息 将于2025年9月30日支付 [10] - 资本支出12亿美元(不含收购) [7] 业绩指引 - 上调2025年收入预期至740-760亿美元 原为728-758亿美元 [11] - 调整后EBITDA预期上调至147-153亿美元 原为143-151亿美元 [12] - 净利润预期上调至61.1-64.8亿美元 原为58.5-62.9亿美元 [12] - EPS预期上调至25.5-27美元 原为24.05-25.85美元 [13] - 预计全年资本支出约50亿美元(不含收购) [13] 同业表现 - Tenet Healthcare第二季度EPS为4.02美元 超出预期41.6% 同比增长74% [16] - Abbott Laboratories第二季度EPS为1.26美元 超出预期0.8% 同比增长10.5% [18] - Edwards Lifesciences第二季度EPS为0.67美元 超出预期8.1% 同比增长8.1% [20]

Key Takeaways PTEN posted a Q2 adjusted loss of $0.06 per share, missing estimates and down from a $0.05 profit last year.Revenues of $1.2B beat estimates but fell 9.6% year over year due to weaker segment contributions.PTEN declared a $0.08 dividend and expects a Q3 rig count of 90 with steady to slightly improved profits.Patterson-UTI Energy, Inc. (PTEN) reported a second-quarter 2025 adjusted net loss of 6 cents per share, which was wider than the Zacks Consensus Estimate of a 4-cent loss. The bottom lin ...

公司财报发布 - HCA Healthcare将于7月25日周五开盘前发布第二季度财报 [1] - 分析师预计公司季度每股收益为6.32美元，高于去年同期的5.5美元，同比增长14.9% [1] - 预计季度营收为185亿美元，较去年同期的174.9亿美元增长5.8% [1] 公司管理层变动 - 7月11日HCA Healthcare任命John W Chidsey III为新任独立董事 [1] 股价表现 - 公司股价周四下跌3.3%，收于341.48美元 [2] 分析师评级 - Truist Securities分析师Ryan Macdonald维持买入评级，目标价从390美元上调至415美元 [7] - 美国银行证券分析师Kevin Fishbeck将评级从买入下调至中性，目标价从394美元上调至410美元 [7] - JP Morgan分析师Benjamin Rossi给予中性评级，目标价380美元 [7] - Keybanc分析师Matthew Gillmor首次覆盖给予增持评级，目标价475美元 [7]